{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:24:00Z","timestamp":1785795840792,"version":"3.56.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/mol.0b013e3283532947","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T13:16:56Z","timestamp":1334668616000},"page":"213-219","source":"Crossref","is-referenced-by-count":55,"title":["Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor"],"prefix":"10.1097","volume":"23","author":[{"given":"Vincenzo","family":"Sorrentino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Zelcer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20211004","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1194\/jlr.R017855","article-title":"Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.","volume":"52","author":"Calandra","year":"2011","journal-title":"J Lipid Res"},{"key":"R2-8-20211004","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1060458","article-title":"Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein.","volume":"292","author":"Garcia","year":"2001","journal-title":"Science"},{"key":"R3-8-20211004","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1168974","article-title":"LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.","volume":"325","author":"Zelcer","year":"2009","journal-title":"Science"},{"key":"R4-8-20211004","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.","volume":"109","author":"Horton","year":"2002","journal-title":"J Clin Invest"},{"key":"R5-8-20211004","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/CIRCRESAHA.110.226878","article-title":"Liver X receptors in atherosclerosis and inflammation.","volume":"108","author":"Im","year":"2011","journal-title":"Circ Res"},{"key":"R6-8-20211004","doi-asserted-by":"crossref","first-page":"36288","DOI":"10.1074\/jbc.274.51.36288","article-title":"MIR is a novel ERM-like protein that interacts with myosin regulatory light chain and inhibits neurite outgrowth.","volume":"274","author":"Olsson","year":"1999","journal-title":"J Biol Chem"},{"key":"R7-8-20211004","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nrm882","article-title":"ERM proteins and merlin: integrators at the cell cortex.","volume":"3","author":"Bretscher","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R8-8-20211004","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev.biochem.78.101807.093809","article-title":"RING domain E3 ubiquitin ligases.","volume":"78","author":"Deshaies","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"R9-8-20211004","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1128\/MCB.01469-10","article-title":"Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver X receptor agonists.","volume":"31","author":"Scotti","year":"2011","journal-title":"Mol Cell Biol"},{"key":"R10-8-20211004","doi-asserted-by":"crossref","first-page":"30190","DOI":"10.1074\/jbc.M111.249557","article-title":"Distinct functional domains contribute to degradation of the low density lipoprotein receptor (LDLR) by the E3 ubiquitin ligase inducible degrader of the LDLR (IDOL).","volume":"286","author":"Sorrentino","year":"2011","journal-title":"J Biol Chem"},{"key":"R11-8-20211004","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1126\/science.1127085","article-title":"Proteasome-independent functions of ubiquitin in endocytosis and signaling.","volume":"315","author":"Mukhopadhyay","year":"2007","journal-title":"Science"},{"key":"R12-8-20211004","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1101\/gad.2056211","article-title":"The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor.","volume":"25","author":"Zhang","year":"2011","journal-title":"Genes Dev"},{"key":"R13-8-20211004","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0969-2126(03)00068-6","article-title":"Origins of peptide selectivity and phosphoinositide binding revealed by structures of disabled-1 PTB domain complexes.","volume":"11","author":"Stolt","year":"2003","journal-title":"Structure"},{"key":"R14-8-20211004","doi-asserted-by":"crossref","first-page":"20107","DOI":"10.1073\/pnas.1111589108","article-title":"FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors.","volume":"108","author":"Calkin","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R15-8-20211004","doi-asserted-by":"crossref","first-page":"19720","DOI":"10.1074\/jbc.M110.123729","article-title":"The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2.","volume":"285","author":"Hong","year":"2010","journal-title":"J Biol Chem"},{"key":"R16-8-20211004","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1326-5-44","article-title":"Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid- peptides in the cerebral spinal fluid of rats.","volume":"5","author":"Suon","year":"2010","journal-title":"Mol Neurodegener"},{"key":"R17-8-20211004","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0092-8674(00)80782-5","article-title":"Reelerdisabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2.","volume":"97","author":"Trommsdorff","year":"1999","journal-title":"Cell"},{"key":"R18-8-20211004","doi-asserted-by":"crossref","first-page":"13878","DOI":"10.1073\/pnas.172510899","article-title":"Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration.","volume":"99","author":"Wang","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-8-20211004","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jacc.2011.09.054","article-title":"Transcriptome characterization of estrogen-treated human myocardium identifies Myosin regulatory light chain interacting protein as a sex-specific element influencing contractile function.","volume":"59","author":"Kararigas","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R20-8-20211004","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1194\/jlr.M006163","article-title":"Reduced VLDL clearance in Apoe()Npc1() mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels.","volume":"51","author":"Ishibashi","year":"2010","journal-title":"J Lipid Res"},{"key":"R21-8-20211004","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1172\/JCI200523915","article-title":"Targeted inactivation of hepatic ABCA1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.","volume":"115","author":"Timmins","year":"2005","journal-title":"J Clin Invest"},{"key":"R22-8-20211004","doi-asserted-by":"crossref","first-page":"e1000730","DOI":"10.1371\/journal.pgen.1000730","article-title":"Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis.","volume":"5","author":"Chasman","year":"2009","journal-title":"PLoS Genet"},{"key":"R23-8-20211004","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids.","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"R24-8-20211004","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/ATVBAHA.109.201020","article-title":"Genetic variants influencing circulating lipid levels and risk of coronary artery disease.","volume":"30","author":"Waterworth","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R25-8-20211004","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1172\/JCI45504","article-title":"The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans.","volume":"121","author":"Weissglas-Volkov","year":"2011","journal-title":"J Clin Invest"},{"key":"R26-8-20211004","first-page":"103","article-title":"Suppression of Idol expression is an additional mechanism underlying statin-induced up-regulation of hepatic LDL receptor expression.","volume":"27","author":"Dong","year":"2011","journal-title":"Int J Mol Med"},{"key":"R28-8-20211004","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1158\/2159-8290.CD-11-0102","article-title":"An LXR agonist promotes GBM cell death through inhibition of an EGFRAKTSREBP-1LDLR-dependent pathway.","volume":"1","author":"Guo","year":"2011","journal-title":"Cancer Discov"},{"issue":"Suppl","key":"R29-8-20211004","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1194\/jlr.R800091-JLR200","article-title":"PCSK9: a convertase that coordinates LDL catabolism.","volume":"50","author":"Horton","year":"2009","journal-title":"J Lipid Res"},{"key":"R30-8-20211004","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1074\/jbc.M708098200","article-title":"The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2.","volume":"283","author":"Poirier","year":"2008","journal-title":"J Biol Chem"},{"key":"R31-8-20211004","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice.","volume":"116","author":"Lagace","year":"2006","journal-title":"J Clin Invest"},{"key":"R32-8-20211004","doi-asserted-by":"crossref","first-page":"28856","DOI":"10.1074\/jbc.M109.037085","article-title":"Dissection of the endogenous cellular pathways of PCSK9-induced low density lipoprotein receptor degradation: evidence for an intracellular route.","volume":"284","author":"Poirier","year":"2009","journal-title":"J Biol Chem"},{"key":"R33-8-20211004","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymgme.2009.09.012","article-title":"A chimeric LDL receptor containing the cytoplasmic domain of the transferrin receptor is degraded by PCSK9.","volume":"99","author":"Holla","year":"2010","journal-title":"Mol Genet Metab"},{"key":"R34-8-20211004","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2010.05.003","article-title":"Disrupted recycling of the low density lipoprotein receptor by PCSK9 is not mediated by residues of the cytoplasmic domain.","volume":"101","author":"Strom","year":"2010","journal-title":"Mol Genet Metab"},{"key":"R35-8-20211004","doi-asserted-by":"crossref","first-page":"31791","DOI":"10.1074\/jbc.M805971200","article-title":"Annexin A2 is a C-terminal PCSK9-binding protein that regulates endogenous low density lipoprotein receptor levels.","volume":"283","author":"Mayer","year":"2008","journal-title":"J Biol Chem"},{"key":"R36-8-20211004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2005.11.014","article-title":"Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake.","volume":"3","author":"Gong","year":"2006","journal-title":"Cell Metab"},{"key":"R37-8-20211004","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cmet.2011.01.015","article-title":"Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase.","volume":"13","author":"Gill","year":"2011","journal-title":"Cell Metab"},{"key":"R38-8-20211004","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1172\/JCI44736","article-title":"Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells.","volume":"121","author":"Kim","year":"2011","journal-title":"J Clin Invest"},{"key":"R39-8-20211004","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/cr.2008.61","article-title":"Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase.","volume":"18","author":"DeBose-Boyd","year":"2008","journal-title":"Cell Res"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00041433-201206000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T01:53:16Z","timestamp":1633312396000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041433-201206000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0b013e3283532947","relation":{},"ISSN":["0957-9672"],"issn-type":[{"value":"0957-9672","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}